Nancy Silliman

Nancy Silliman is an accomplished leader in the field of data science, statistics, and epidemiology, currently serving as Senior Vice President at Alnylam Pharmaceuticals since August 2018. With a robust background that includes key leadership roles at Alexion Pharmaceuticals and Genzyme, Nancy has extensive experience in biostatistics, data management, and programming. Nancy's academic credentials include a PhD and MS in Statistics from Carnegie Mellon University, complemented by a BA in Mathematics and German from Hamilton College. With a career spanning over two decades in the pharmaceutical industry, Nancy has demonstrated expertise in driving innovative statistical methodologies and analytics.